Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3016% below fair value
$394.48+4.32 (+1.11%)
Close on Nov 20, 2026Market cap $85.23BP/E 16.8Yield –
Elevance Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Elevance Health's free cash flow for the twelve months ending Sep 30, 2026 was $6.51B, up 72.9% year over year. For fiscal 2025 it was $3.17B, down 30.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is $9.67B in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.17B | -30.3% |
| FY2024 | Dec 31, 2024 | $4.55B | -32.7% |
| FY2023 | Dec 31, 2023 | $6.77B | -6.7% |
| FY2022 | Dec 31, 2022 | $7.25B | -0.4% |
| FY2021 | Dec 31, 2021 | $7.28B | -24.7% |
| FY2020 | Dec 31, 2020 | $9.67B | +94.0% |
| FY2019 | Dec 31, 2019 | $4.98B | +90.3% |
| FY2018 | Dec 31, 2018 | $2.62B | -22.8% |
| FY2017 | Dec 31, 2017 | $3.39B | +26.4% |
| FY2016 | Dec 31, 2016 | $2.69B | -24.8% |
| FY2015 | Dec 31, 2015 | $3.57B | +34.6% |
| FY2014 | Dec 31, 2014 | $2.65B | +10.3% |
| FY2013 | Dec 31, 2013 | $2.41B | +9.4% |
| FY2012 | Dec 31, 2012 | $2.20B | -23.0% |
| FY2011 | Dec 31, 2011 | $2.85B | +195.8% |
| FY2010 | Dec 31, 2010 | $965.30M | -63.7% |
| FY2009 | Dec 31, 2009 | $2.66B | +21.5% |
| FY2008 | Dec 31, 2008 | $2.19B | -45.6% |
| FY2007 | Dec 31, 2007 | $4.02B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.00B | +29.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.63B | -9.0% |
| Q1 FY2026 | Mar 31, 2026 | $4.10B | +399.0% |
| Q4 FY2025 | Dec 31, 2025 | -$209.00M | -154.4% |
| Q3 FY2025 | Sep 30, 2025 | $775.00M | -67.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.79B | +1341.1% |
| Q1 FY2025 | Mar 31, 2025 | $821.00M | -51.7% |
| Q4 FY2024 | Dec 31, 2024 | $384.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $2.35B | +2.2% |
| Q2 FY2024 | Jun 30, 2024 | $124.00M | -92.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.70B | -72.5% |
| Q4 FY2023 | Dec 31, 2023 | -$3.30B | – |
| Q3 FY2023 | Sep 30, 2023 | $2.29B | -50.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.60B | -25.8% |
| Q1 FY2023 | Mar 31, 2023 | $6.17B | +169.7% |
| Q4 FY2022 | Dec 31, 2022 | -$1.82B | -236.3% |
| Q3 FY2022 | Sep 30, 2022 | $4.62B | +105.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.16B | +54.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.29B | -0.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.33B | -62.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.25B | – |
| Q2 FY2021 | Jun 30, 2021 | $1.40B | -73.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.30B | -0.4% |
| Q4 FY2020 | Dec 31, 2020 | $3.54B | +262.2% |
| Q3 FY2020 | Sep 30, 2020 | -$1.46B | -204.3% |
| Q2 FY2020 | Jun 30, 2020 | $5.28B | +334.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.31B | +65.5% |
| Q4 FY2019 | Dec 31, 2019 | $976.00M | +582.5% |
| Q3 FY2019 | Sep 30, 2019 | $1.40B | +454.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.22B | +435.7% |
| Q1 FY2019 | Mar 31, 2019 | $1.40B | -30.1% |
| Q4 FY2018 | Dec 31, 2018 | $143.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $252.00M | -88.5% |
| Q2 FY2018 | Jun 30, 2018 | $227.00M | +1.6% |
| Q1 FY2018 | Mar 31, 2018 | $2.00B | -22.0% |
| Q4 FY2017 | Dec 31, 2017 | -$1.58B | -1556.6% |
| Q3 FY2017 | Sep 30, 2017 | $2.19B | – |
| Q2 FY2017 | Jun 30, 2017 | $223.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.56B | – |
| Q4 FY2016 | Dec 31, 2016 | $108.20M | – |
See a number that looks wrong?